United States · 
Who invested in ReCode Therapeutics?
ReCode Therapeutics's investors include OrbiMed and Sanofi.
United States · Funded startup
Who invested in ReCode Therapeutics
Funding summaryUpdated 26 Oct 2026
$29Mraised across 1 round since 2025, from 1 source
- Latest round
- Debt, $29MSept 2025
- Investors
- 2
The rounds
- Sept 2025
Founders and team
From ReCode Therapeutics's own website: 1 on the team.
- Dean J. MitchellChairman, Board of Directors
AdvisersScientific Advisor
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about ReCode Therapeutics
How much has ReCode Therapeutics raised?
ReCode Therapeutics has raised $29M across 1 round since 2025.
When did ReCode Therapeutics last raise?
ReCode Therapeutics's most recent round was a Debt of $29M in Sept 2025.
What was ReCode Therapeutics's biggest round?
Its most recent round, $29M in Sept 2025, is also its largest on record.
Who backed ReCode Therapeutics first?
ReCode Therapeutics's first round on record, in Sept 2025, was backed by OrbiMed and Sanofi.
What stage is ReCode Therapeutics at?
ReCode Therapeutics's latest named round is a Debt, in Sept 2025.
Where is ReCode Therapeutics based?
ReCode Therapeutics is based in the United States.
Companies like ReCode Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.